Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.
about
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast CancerEpigenetic suppression of neprilysin regulates breast cancer invasionThe role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.
P2860
Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.
@en
type
label
Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.
@en
prefLabel
Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.
@en
P2093
P2860
P356
P1433
P1476
Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.
@en
P2093
Alla Sikorskii
Burra V Madhukar
Cheryl Leece
David A Wiese
Kathleen A Gallo
Nikolay V Dimitrov
Shalini Chitneni
Simona C Chivu
P2860
P304
P356
10.1155/2013/385398
P577
2013-06-12T00:00:00Z